United States· US:71335-0782_c5595381-c3bc-43a4-9c65-0b68b454a891

Methotrexate

A methotrexate product containing methotrexate sodium, registered in United States by Bryant Ranch Prepack. The same ATC class is registered in 15 of our 19 countries.

ATC L04AX03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMethotrexateATCL04AX03REGISTER NO.US:71335-0782_c559538…PACKS LISTED16CHECKEDSeptember 27, 2026

Where it is registered

Methotrexate is registered in 15 of 19 countries.

Countries holding a registration under ATC L04AX03 (methotrexate), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Methotrexate · ATC L04AX03

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of methotrexate costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.16 in United States to $5.98 in Switzerland — a ×38 gap.

  • United States: $0.16 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Methotrexate · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$5.98
  • IT Italy$0.20
  • US United States$0.16 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHOTREXATE SODIUM
Manufacturer
Bryant Ranch Prepack
Country
United States (US)
ATC code
L04AX03
ATC class
Methotrexate
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 16

  • ndc11
    7133507821
    30 TABLET in 1 BOTTLE (71335-0782-1)
  • ndc11
    7133507822
    12 TABLET in 1 BOTTLE (71335-0782-2)
  • ndc11
    7133507823
    20 TABLET in 1 BOTTLE (71335-0782-3)
  • ndc11
    7133507824
    100 TABLET in 1 BOTTLE (71335-0782-4)
  • ndc11
    7133507825
    36 TABLET in 1 BOTTLE (71335-0782-5)
  • ndc11
    7133507826
    24 TABLET in 1 BOTTLE (71335-0782-6)
  • ndc11
    7133507827
    90 TABLET in 1 BOTTLE (71335-0782-7)
  • ndc11
    7133507828
    4 TABLET in 1 BOTTLE (71335-0782-8)
  • ndc11
    71335-0782-1
  • ndc11
    71335-0782-2
  • ndc11
    71335-0782-3
  • ndc11
    71335-0782-4
  • ndc11
    71335-0782-5
  • ndc11
    71335-0782-6
  • ndc11
    71335-0782-7
  • ndc11
    71335-0782-8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

929 interactions on record for methotrexate.

Graded by severity as the source publishes them — 107 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methotrexate · interactions on record

929 records

  • 107 severe
  • 466 moderate
  • 17 minor
  • 309 info

Most severe, free to view

  • OmeprazoleA02BC01severe
  • PantoprazoleA02BC02severe
  • LansoprazoleA02BC03severe
  • RabeprazoleA02BC04severe

30 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/72580b62-1ac4-4325-bf47-86b16c30e96b
GET /v1/drugs/72580b62-1ac4-4325-bf47-86b16c30e96b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "2.5",
  "substance": "METHOTREXATE SODIUM",
  "productndc": "71335-0782",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA081099",
  "marketing_category": "ANDA"
}

See everything about methotrexate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.